Jci_page_head_homepage_01 Jci_page_head_homepage_02
Kazuya Takahashi, Sachiko Miyake, Takayuki Kondo, Keiji Terao, Megumi Hatakenaka, Shuji Hashimoto, Takashi Yamamura
Published in Volume 107, Issue 5
J Clin Invest. 2001; 107(5):0–0 doi:10.1172/JCI11819
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 5

Involvement of IL-5 in the Th1 inhibition by NK2 cells. Freshly isolated T cells were mixed with or without NK2 cells obtained from the same donor and were stimulated with PMA/ionomycin for 6 hours as performed in the experiment in Figure 4. To ascertain the role of IL-5, a neutralizing anti–IL-5 mAb (T with NK2+αIL-5), an isotype-matched control mAb (T with NK2), or recombinant IL-5 (100 pg/ml) was added to the culture. The stimulated cells were permeabilized and stained with anti-human CD3-PerCP, anti–CD56-FITC, and anti–IFNγ-PE. This is a representative of two experiments with similar results. T, T cells.